Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy.
about
Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable diseaseImpact of radiation avoidance on survival and neurocognitive outcome in infant medulloblastoma.Evaluation of age-dependent treatment strategies for children and young adults with pineoblastoma: analysis of pooled European Society for Paediatric Oncology (SIOP-E) and US Head Start data.Primary central nervous system primitive neuroectodermal tumors (CNS-PNETs) of the spinal cord in children: four cases from the German HIT database with a critical review of the literature.Overcoming multiple drug resistance mechanisms in medulloblastoma.Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology.Histology predicts a favorable outcome in young children with desmoplastic medulloblastoma: a report from the children's oncology group.Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasmsPI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven Medulloblastoma.The molecular classification of medulloblastoma: driving the next generation clinical trials.Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variablesPilot study of systemic and intrathecal mafosfamide followed by conformal radiation for infants with intracranial central nervous system tumors: a pediatric brain tumor consortium study (PBTC-001)Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy.Radiotherapy-induced malignancies: review of clinical features, pathobiology, and evolving approaches for mitigating riskMedulloblastoma comprises four distinct molecular variants.Pediatric Brain Tumors: Current Knowledge and Therapeutic OpportunitiesTreatment Options for Medulloblastoma and CNS Primitive Neuroectodermal Tumor (PNET)The rationale for targeted therapies in medulloblastoma.Feasibility of conducting long-term follow-up of children and infants treated for CNS tumors on the same cooperative group clinical trial protocol.Treatment of posterior fossa tumors in children.The biologic era of childhood medulloblastoma and clues to novel therapies.Factors affecting survival of medulloblastoma in children: the changing concept of management.Survival after chemotherapy and stem cell transplant followed by delayed craniospinal irradiation is comparable to upfront craniospinal irradiation in pediatric embryonal brain tumor patients.Identification of c-myc-dependent proteins in the medulloblastoma cell line D425Med.Frequency, risk-factors and survival of children with atypical teratoid rhabdoid tumors (AT/RT) of the CNS diagnosed between 1988 and 2004, and registered to the German HIT database.Desmoplastic Nodular Medulloblastoma in Young Children: A Management Dilemma.Management and outcomes of treating pediatric medulloblastoma: an eight years' experience in an Iranian pediatric center.Intellectual and academic outcome following two chemotherapy regimens and radiotherapy for average-risk medulloblastoma: COG A9961.Somatostatin receptor subtype 2 (sst₂) is a potential prognostic marker and a therapeutic target in medulloblastoma.Bortezomib stabilizes NOXA and triggers ROS-associated apoptosis in medulloblastoma.Treatment of medulloblastoma in children and adolescents.Histological variants of medulloblastoma are the most powerful clinical prognostic indicators.
P2860
Q24310764-92CFD30F-A8BD-4766-8865-EA1330EDFD8CQ30383556-AC6197A0-BC68-4152-B603-B555D976F455Q31151075-08DF69D5-CBD5-468F-BB71-786FB3305111Q33779142-A0410291-BCF4-41D6-8063-2B2A9147780FQ34500602-44932F3E-FFB2-4E45-B14C-BB26982C4CE7Q35021335-73ADD5E1-0162-471D-965A-BF98A4185F45Q35058988-79F74A49-9F16-409D-A285-1CE4EFE74BC2Q35127713-BC19229B-3C82-4C6A-A5E4-5403DFFC9488Q35944343-0C5BBE8E-705C-49BC-A462-7CD1DD1B3D83Q35946293-17794AE5-2505-427D-B56A-BBE07505DE8EQ36476670-F4794C44-5528-4B97-82C4-BDAB15DD179FQ36485382-9CB34731-2347-4E0A-8F06-2D0768980E44Q36544096-99A3AFD4-A12A-4A40-BC15-373FAB5EBB71Q36736612-D1C5E6F1-C854-4EC8-A3AA-106AB18D71FBQ36920479-BF983A20-9C5F-450E-9210-CC8CE5E6DFDFQ37213305-D06E708D-2623-483A-BB5D-12FAE1631074Q37261835-2687819E-541D-4627-9132-2665DA844B65Q37409736-E979BCB6-D472-4316-96EE-4362FD7CE890Q37478367-FA2193EE-0BFA-469C-B1BD-EDB484B86890Q37724213-35DC62A7-FC25-40CD-B115-3E769D5759C1Q38206276-F86EB837-844F-422D-9EFA-1CD4CC949F2EQ38583250-B04A75DC-805A-4D60-A4EB-5B546156D2C4Q38806100-21FA04C1-48B3-4B0C-A584-58C1269244A5Q39525739-F8EC0D16-4294-4ADB-848E-3A5185F6FA75Q43944813-A652774A-BBF3-4C44-8700-06B79D80B45DQ47284266-ACC13D0F-FB9E-42FF-86A1-525C64BA78F7Q47353908-0E9D9899-5575-4A64-90DC-4735E1720BEBQ48147298-279DDC42-895A-45FA-BF3B-B676AFA72D1FQ50744249-14C67A1C-0C15-4B7A-B0FF-490E9EA20E6BQ53243559-6696A8FA-0BBD-4946-9D5E-5D04ED827E2DQ55459129-6273F590-038C-401A-A200-E74931EC8C56Q55462103-22FEB71D-F393-4071-92D0-76929EE867D6
P2860
Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treatment of early childhood m ...... apy and deferred radiotherapy.
@en
Treatment of early childhood m ...... apy and deferred radiotherapy.
@nl
type
label
Treatment of early childhood m ...... apy and deferred radiotherapy.
@en
Treatment of early childhood m ...... apy and deferred radiotherapy.
@nl
prefLabel
Treatment of early childhood m ...... apy and deferred radiotherapy.
@en
Treatment of early childhood m ...... apy and deferred radiotherapy.
@nl
P2093
P2860
P921
P1433
P1476
Treatment of early childhood m ...... apy and deferred radiotherapy.
@en
P2093
Angela Emser
Astrid Gnekow
Frank Berthold
Frank Deinlein
German Pediatric Brain Tumor Study Group
Günter Henze
Holger Ottensmeier
Joachim Kuehl
Johannes E A Wolff
Katja von Hoff
P2860
P304
P356
10.1215/15228517-2008-084
P577
2008-09-25T00:00:00Z